Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 29.25
Key Takeaways
Risk factor
Low price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Slightly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Guobang Pharma Ltd. engages in the research and development, production, and sale of medical products for human and animals in China. It offers medical products, including APIs, medication intermediates related to the API, and formulations; and veterinary products, such as APIs for animals, additives, and formulations. The company was founded in 1996 and is based...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EB
Data is available to registered users only
Buy
Sell